SEMA3E and obesity due to melanocortin 4 receptor deficiency: In addition to mice with dietary obesity, the circulating Sema3E level is also increased in patients with diabetes, suggesting that suppression of this secreted molecule could become a next generation therapy for diabetes by inhibiting chronic inflammation in visceral WAT4.